Insulin

A new systematic review and meta-analysis published in the British Medical Journal has concluded adhering to a low-carbohydrate diet for six months is the most effective dietary strategy to put type type 2 diabetes into remission.

An incredible proof-of-concept study has demonstrated the development of a novel insulin molecule that can sense blood sugar levels and self-adjust its activity in response to a patient’s needs, raising hopes of a safer and easier insulin therapy.

A new study has discovered a previously unknown mechanism by which a hormone released from the gut hours after eating effectively switches off the body’s fat production processes, and found this mechanism is defective in those with fatty liver disease.

Thanks to a newfound understanding of the way insulin secretion is triggered in pancreatic cells, scientists at the University of Wisconsin (UW)-Madison have uncovered an exciting new pathway in the treatment of type 2 diabetes.

A research group at the University of Iowa has built what is described as a "remote control" for diabetes management that uses electromagnetic fields (EMFs) to reduce blood sugar levels and improve the body’s response to insulin.

A new study is suggesting a strong coffee first thing in the morning, especially following a night of disrupted sleep, can impair the body’s glucose response. The researchers recommend coffee should consumed in the morning after food, and not before.

The promising results of a Phase 2 trial testing a new, once-weekly insulin treatment for type 2 diabetes have been published. The weekly injection was found to be as safe and effective as daily insulin shots and a larger Phase 3 trial is currently being planned.

New research carried out in Singapore demonstrates how magnets can be used to pinch and apply pressure to the skin, which opens up additional pathways for drugs such as insulin to enter the body in safer, more efficient ways.

Researchers have developed an ultrafast-acting form of insulin that promises to work up to four times faster than current formulations. The novel drug has only been tested in animals so far but the researchers hope to test it in human trials soon.

Scientists at the University of Utah have borrowed useful elements of cone snail venom to produce a potent hybrid “mini-insulin” that acts far more swiftly, and could make treating diabetes far more effective as a result.

Imagine a device that lets people with diabetes use an app to give themselves a boost of insulin when they need it, without an injection. A prototype device can do just that, using electricity to control gene expression in encapsulated beta cells.

A new experimental drug could help mitigate some of the dangerous side effects caused by a once-promising diabetes medication. Animal tests suggest the combination treatment is both safe and effective at helping regulate blood sugar levels in diabetics.